logo-loader

Capital Network analyst sees 'significant upside opportunity' at Synnovia

Published: 07:25 09 Jul 2019 EDT

Capital Network analyst Ed Stacey discusses Synnovia's (LON:SYN) results for the year to the end of March 2019.

Revenues increased 8.7% to £81.6mln, earnings before interest, tax, depreciation, and amortisation (EBITDA) were up 7.3% at £7.5mln, and earnings per share (EPS) were up 2.1% at 9.7p.

Stacey says the company has an established record of revenue growth and a significant upside opportunity in improving profit margins.

He believes the valuation could re-rate upwards as risk factors such as Brexit uncertainty begin to dissipate.

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

12 minutes ago